CD274 and neoplasm: In early 2018, two groups described 3D microfluidic-based culture to recapitulate anti-PD1/PDL1 cancer immunotherapy using mouse-derived and patient-derived organotypic tumor spheroids (MDOTS and PDOTS, respectively) (39, 40).